The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Clinical lymphedema exacerbation rate
Lymphedema outcomes include: incident events requiring medical care for lymphedema (e.g. flare-ups or cellulitic infections), arm swelling in the affected limb (Interlimb volume differences), and pain & lymphedema symptoms (number and severity)
Baseline, 6, and 12 months
No
Kathryn H. Schmitz, MPH,PhD
Principal Investigator
University of Pennsylvania
United States: Institutional Review Board
U54-CA 155850
NCT01515124
January 2012
June 2016
Name | Location |
---|---|
The University of Pennsylvania TREC Survivorship Center/ Perelman School of Medicine | Philadelphia, Pennsylvania 19104 |